PHILADELPHIA and VANCOUVER, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the ...

Following promising phase 1 data, TCMCB07 is being further evaluated in a phase 2 trial for the treatment of patients with stage IV colorectal cancer. The first patient with stage IV colorectal cancer ...

Dive into Sprunki Phase 2 Definitive, where music and gaming collide! Create, compose, and share your unique soundtracks in a vibrant, interactive world.

The registration deadline for Round 2 of the Prime Minister Internship Scheme 2025 has been extended to April 15, giving students and young professionals more time to apply. The scheme offers year ...

Endevica Bio's phase 2 trial of TCMCB07 aims to prevent weight loss in mCRC patients undergoing chemotherapy, addressing cancer cachexia. TCMCB07, a melanocortin-3/4 antagonist peptide, crosses the ...

SOUTH BEND, Ind. (WNDU) - The Ireland Road and Ironwood Drive Intersection Improvement Project has moved into Phase 2. Officials say work has shifted to the northeast corner of the intersection.

Prime Narendra Modi has cancelled the programme scheduled in Kanpur on April 24 in the wake of Pahalgam terror attack, which claimed 26 lives. The Prime Minister was ...

Construction on the U.S. 31 project in Franklin began on April 7 and will continue until summer 2028. JOHNSON COUNTY – Indiana Department of Transportation contractor Milestone Contractors is ...

This experiment belongs to Digital Logic Design ( Logic Gates & Mux-Demux ) Lab IITB. Full Name: Implementation of 8:1 multiplexer using MSI ICs ...

The total construction cost is $3.8 million. According to a news release, next week, construction crews will begin Phase 2, Step 1 of the construction process. Adjacent roadways will not be ...

Iadademstat, a selective LSD1 inhibitor, is being tested with immune checkpoint inhibitors for extensive-stage SCLC in a phase 1/2 trial. The trial, led by the National Cancer Institute, evaluates ...

Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...